Hormone Replacement Therapy Market Strategic Analysis 2019 to 2024 | Expected to Grow xx% CAGR of Top Key Players and Regions
The Research Report on “Hormone Replacement Therapy Market” 2019 report includes every aspect of the Hormone Replacement Therapy industry along with the progress performance. Hormone Replacement Therapy Market report presents an analysis of market size, share, and growth, trends, and price structure, statistical and detailed data of the Hormone Replacement Therapy industry. Additionally, Hormone Replacement Therapy Market 2019 research report offers key analysis on the industry status of the Hormone Replacement Therapy producers with market size, growth, share, trends as well as business price structure.
The Hormone Replacement Therapy Market report is a professional and detailed study on the Hormone Replacement Therapy business. Hormone Replacement Therapy market to predict future market directions between the forecast periods from 2019 to 2024 providing you with vital data for your business decisions.
Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14244100
Scope of the Report:
Hormone Replacement Therapy Report Also Covers Offer for New Project Includes:
- Market Entry Strategies
- Countermeasures of Economic Impact
- Marketing Channels
- Feasibility Studies of New Project Investment
- Research Conclusions of the Hormone Replacement Therapy Industry
The report provides key statistics on the market status of the Hormone Replacement Therapy Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Hormone Replacement Therapy .
Enquire Before Purchasing this Report – https://www.industryresearch.co/enquiry/pre-order-enquiry/14244100
Hormone Replacement Therapy Market Report Also Covers Marketing Strategy Analysis, Top Manufacturers:
Key Market Trends:
In Therapy Segment, Estrogen Replacement Therapy is Expected to Show the Fastest Growth, over the Forecast Period
The most common form of estrogen replacement therapy (ERT) is oral medication. Besides, ERT is also available in the commercial market, in the form of pills, patches, and suppositories.
The most prominently consumed oral ERT variants include conjugated estrogens (Premarin), estradiol (Estrace), and Estratab. ERTs are an effective treatment option for female patients suffering from menopause symptoms. However, there are several side effects associated with the usage of ERTs. Oral ERTs are associated with strokes, blood clots, and some cases of cancer. These side effects have been well documented in the form of moderate-severe adverse drug reactions (ADRs).
These ADRs are expected to cause some erosion in the popularity of ERTs. However, their adoption rate is expected to increase over the forecast period, globally, due to the increasing prevalence of hormonal imbalance issues among the geriatric people and pregnant women.
United States Holds the Largest Share in the North American Region
Rising geriatric population is one of the primary factors responsible for the growth of the hormonal replacement therapy market in the United States.
According to the National Institutes of Health (NIH), almost half of all the postmenopausal women in the United States reported having used HRT at least once in their life. The conjugated equine estrogens (CEE)/bazedoxifene tablet, a combination of estrogen and a selective estrogen receptor modulator, is available in the United States for menopausal VMS treatment and osteoporosis prevention.
Three organizations, namely, the American College of Obstetricians and Gynecologists, the North American Menopause Society (NAMS), and the Endocrine Society, have produced guidelines on the use of HRT during menopause. As of 2016, there were 15 producers of estrogens and eight producers of progestins. In 2016, the top-selling HRT-based drug was Premarin, with a market share greater than 50% among HRTs. Consequently, Premarin became the fifth most prescribed drug in the country.
Overall, the market for HRT in the United States is scheduled for high growth over the forecast period. The major drivers of this market are expected to increase the adoption of HRT among women, for both post-menopausal and menopause management.
Purchase this Report (Price 4250 USD for Single User License) – https://www.industryresearch.co/purchase/14244100
Detailed TOC of Hormone Replacement Therapy Market Report are:
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Awareness on Post-menopausal Issues among Women
4.2.2 Rise in Drug Development with Novel Delivery Systems
4.2.3 Hormonal Imbalance Disorders with Rising Geriatric Population
4.3 Market Restraints
4.3.1 High Cost of Hormone Replacement Therapy
4.3.2 Substantial Risk of Cancer Associated with Hormone Replacement Therapy
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Therapy
5.1.1 Estrogen Hormone Replacement
5.1.2 Growth Hormone Replacement
5.1.3 Thyroid Hormone Replacement
5.1.4 Testosterone Replacement
5.2 By Route of Administration
5.2.3 Other Routes of Administration
5.3 By Disease
5.3.3 Growth Hormone Deficiency
5.3.4 Other Diseases
5.4.1 North America
184.108.40.206 United States
220.127.116.11 United Kingdom
18.104.22.168 Rest of Europe
22.214.171.124 South Korea
126.96.36.199 Rest of Asia-Pacific
5.4.4 Middle East & Africa
188.8.131.52 South Africa
184.108.40.206 Rest of Middle East & Africa
5.4.5 South America
220.127.116.11 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Bayer AG
6.1.3 Eli Lilly and Company
6.1.4 F. Hoffmann-La Roche
6.1.5 Hisamitsu Pharmaceutical Co. Inc.
6.1.6 Merck KGaA
6.1.7 Mylan NV
6.1.8 Novartis AG
6.1.9 Novo Nordisk AS
6.1.10 Pfizer Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Name: Ajay More
Phone: US +14242530807/ UK +44 20 3239 8187
Email: [email protected]
Our Other Reports: